Tenaya Therapeutics, Inc.
TNYA
$1.22
-$0.06-4.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.97% | 3.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.06% | -12.55% | |||
| Operating Income | 13.06% | 12.55% | |||
| Income Before Tax | 12.92% | 13.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.92% | 13.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.92% | 13.33% | |||
| EBIT | 13.06% | 12.55% | |||
| EBITDA | 13.30% | 11.57% | |||
| EPS Basic | 13.22% | 41.51% | |||
| Normalized Basic EPS | 13.20% | 41.49% | |||
| EPS Diluted | 13.22% | 41.51% | |||
| Normalized Diluted EPS | 13.20% | 41.49% | |||
| Average Basic Shares Outstanding | 0.34% | 48.17% | |||
| Average Diluted Shares Outstanding | 0.34% | 48.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||